These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11600518)

  • 1. Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass.
    Smit JW; Janssen YJ; Lamb HJ; van der Wall EE; Stokkel MP; Viergever E; Biermasz NR; Bax JJ; Vliegen HW; de Roos A; Romijn JA; Roelfsema F
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4638-43. PubMed ID: 11600518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-months of recombinant human GH therapy in patients with ischemic cardiac failure.
    van Thiel SW; Smit JW; de Roos A; Bax JJ; van der Wall EE; Biermasz NR; Viergever E; Vliegen HW; Romijn JA; Roelfsema F; Lamb HJ
    Int J Cardiovasc Imaging; 2004 Feb; 20(1):53-60. PubMed ID: 15055821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.
    Osterziel KJ; Strohm O; Schuler J; Friedrich M; Hänlein D; Willenbrock R; Anker SD; Poole-Wilson PA; Ranke MB; Dietz R
    Lancet; 1998 Apr; 351(9111):1233-7. PubMed ID: 9643742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human growth hormone treatment for dilated cardiomyopathy in children.
    McElhinney DB; Colan SD; Moran AM; Wypij D; Lin M; Majzoub JA; Crawford EC; Bartlett JM; McGrath EA; Newburger JW
    Pediatrics; 2004 Oct; 114(4):e452-8. PubMed ID: 15466071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The severity of chronic heart failure due to coronary artery disease predicts the endocrine effects of short-term growth hormone administration.
    Osterziel KJ; Blum WF; Strohm O; Dietz R
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1533-9. PubMed ID: 10770193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
    Colao A; di Somma C; Cuocolo A; Spinelli L; Tedesco N; Pivonello R; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R; Cianci G; Gigli M; Mazzanti M; Lacalaprice F
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
    Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
    Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of dilated cardiomyopathy with recombinant human growth hormone].
    Osterziel KJ; Markus U; Willenbrock R; Strohm O; Dietz R
    Z Kardiol; 1997 Oct; 86(10):803-11. PubMed ID: 9454447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Kourea K; Panou F; Farmakis D; Paraskevaidis I; Ikonomidis I; Filippatos G; Kremastinos DT
    Am Heart J; 2008 Apr; 155(4):751.e1-7. PubMed ID: 18371487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
    Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
    J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction.
    Rong SL; Wang YJ; Wang XL; Lu YX; Chang C; Wang FZ; Liu QY; Liu XY; Gao YZ; Mi SH
    Chin Med J (Engl); 2009 Oct; 122(19):2352-9. PubMed ID: 20079139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.
    Mulumba M; Céméus C; Dumont L; du Souich P; Ong H; Marleau S
    Growth Horm IGF Res; 2007 Apr; 17(2):96-103. PubMed ID: 17280860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis.
    Le Corvoisier P; Hittinger L; Chanson P; Montagne O; Macquin-Mavier I; Maison P
    J Clin Endocrinol Metab; 2007 Jan; 92(1):180-5. PubMed ID: 17062772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Left ventricular mass and function in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska Kostro J; Tołwińska J; Urban M; Głowińska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):75-80. PubMed ID: 15504309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.